Grove AI, a next-generation clinical trial management company, has raised $4.9 million in seed funding, led by A* with support from Afore Capital, LifeX Ventures, Pear VC, Upfront Ventures, and industry-leading angels. This funding will enable Grove to scale its team and product, addressing inefficiencies in clinical trials by creating participant-centered ecosystems powered by real-time data and AI-driven insights.
1. Challenges in Clinical Trials
- Fragmented communication, slow feedback loops, and inefficient workflows.
- High costs for pharmaceutical companies, reaching up to $8M per day in delays.
- Participant frustration and site staff overwhelm hinder trial efficiency.
2. Grove’s Transformative Approach
- Redefines trials through an AI-powered participant relationship management (PRM) platform.
- Key features of Grove’s platform:
- Streamlines participant qualification.
- Enhances engagement and retention rates.
- Delivers actionable insights for smarter and faster trials.
- Grace, Grove’s AI clinical research agent:
- Multilingual, available 24/7.
- Handles prescreening, scheduling, logistics, and follow-ups.
- Powers dynamic feedback loops to reduce staff burnout and improve trial precision.
3. Proven Impact and Results
- Supported tens of thousands of participants across various therapeutic areas.
- Achieved a 97% participant satisfaction rate.
- Accelerated time-to-first visit while enhancing diversity in trials.
4. Industry Endorsements
- Sean Stanton, Co-Founder of K2 Medical Research:
- “Grove streamlined operations, saving thousands of staff hours and prescreening hundreds of participants.”
- “Boosted trial efficiency and scaled operations seamlessly.”
- Gautam Gupta, Co-Founder at A:*
- “Grove equips life sciences leaders with tools to accelerate breakthroughs and achieve greater efficiency.”
With $4.9 million in seed funding, Grove AI is set to revolutionize clinical trials, empowering participants, optimizing workflows, and accelerating breakthroughs in medicine. By leveraging AI and real-time data, Grove bridges gaps in clinical research, transforming trials into efficient and participant-centered ecosystems.
